Revenue (TTM) Chart

View Revenue (TTM) for PMSNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2025 5.854M
December 31, 2024 6.250M
June 30, 2024 5.082M
December 31, 2023 6.236M
June 30, 2023 9.286M
December 31, 2022 9.531M
June 30, 2022 8.515M
December 31, 2021 7.033M
June 30, 2021 6.430M
December 31, 2020 6.066M
June 30, 2020 6.018M
December 31, 2019 5.894M
June 30, 2019 4.466M
December 31, 2018 4.054M
June 30, 2018 4.486M
December 31, 2017 4.374M
June 30, 2017 3.779M
December 31, 2016 3.678M
June 30, 2016 3.188M
December 31, 2015 2.876M
June 30, 2015 2.557M
December 31, 2014 2.571M
June 30, 2014 3.29M
Date Value
December 31, 2013 3.347M
June 30, 2013 1.780M
December 31, 2012 1.686M
June 30, 2012 1.911M
December 31, 2011 1.64M
June 30, 2011 1.188M
December 31, 2010 0.5177M
June 30, 2010 2.319M
December 31, 2009 2.124M
June 30, 2009 0.1963M
December 31, 2008 1.668M
June 30, 2008 1.742M
December 31, 2007 0.5274M
June 30, 2007 0.5065M
December 31, 2006 0.1288M
June 30, 2006
December 31, 2005
June 30, 2005 0.0775M
December 31, 2004 0.1334M
June 30, 2004 0.1878M
December 31, 2003 0.2766M
June 30, 2003 0.4419M
December 31, 2002 0.2668M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Ixico Plc 9.748M
Oxford BioDynamics Plc 1.601M
ICON plc 8.294B
Champions Oncology, Inc. 59.42M
Silence Therapeutics Plc 0.615M